These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6271798)

  • 21. Pharmacokinetics and pharmacodynamics of ranitidine after burn injury.
    Martyn JA; Bishop AL; Oliveri MF
    Clin Pharmacol Ther; 1992 Apr; 51(4):408-14. PubMed ID: 1563210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of ranitidine in serum by high performance liquid chromatography.
    Vandenberghe HM; MacLeod SM; Mahon WA; Lebert PA; Soldin SJ
    Ther Drug Monit; 1980; 2(4):379-84. PubMed ID: 6111854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
    Ashiru DA; Patel R; Basit AW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):235-40. PubMed ID: 18006395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sensitive and rapid determination of ranitidine in human plasma by HPLC with fluorescence detection and its application for a pharmacokinetic study.
    Ulu ST; Tuncel M
    J Chromatogr Sci; 2012 Apr; 50(4):301-6. PubMed ID: 22345389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of oral ranitidine in Mexicans.
    Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V; Herrera-Abarca A; Pérez-Urizar J; Herrera JE; Hong E
    Arch Med Res; 1996; 27(3):349-52. PubMed ID: 8854394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration.
    McFadyen ML; Folb PI; Marks IN; Wright JP; Lucke W
    Scand J Gastroenterol Suppl; 1981 Jun; 69():109-13. PubMed ID: 6119772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption and disposition of ranitidine hydrochloride in rat and dog.
    Eddershaw PJ; Chadwick AP; Higton DM; Fenwick SH; Linacre P; Jenner WN; Bell JA; Manchee GR
    Xenobiotica; 1996 Sep; 26(9):947-56. PubMed ID: 8893041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ranitidine after partial gastrectomy in dogs.
    Makil O; Kaltenbach ML; Limberg J; Harrison D; Hocking MP; Derendorf H
    J Pharm Sci; 1991 Nov; 80(11):1034-6. PubMed ID: 1815053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic properties of ranitidine in Chinese people.
    Hu OY; Pao LH; Chung PH; Tang HS
    Acta Gastroenterol Belg; 1991; 54(5-6):328-35. PubMed ID: 1803834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine kinetics and dynamics. II. Intravenous dose studies and comparison with cimetidine.
    Lebert PA; Mahon WA; MacLeod SM; Soldin SJ; Fenje P; Vandenberghe HM
    Clin Pharmacol Ther; 1981 Oct; 30(4):545-50. PubMed ID: 6269789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of ranitidine on antipyrine metabolism (author's transl)].
    Staiger C; Simon B; de Vries J; Kather H; Walter E
    Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC; Baltodano N; Perez GO; Oster JR; Jallad NS; Weidler DJ
    Pharmacology; 1985; 31(4):189-93. PubMed ID: 4059323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency.
    van Dalen R; Vree TB; Hafkenscheid JC; Gimbrère JS
    J Antimicrob Chemother; 1979 May; 5(3):281-92. PubMed ID: 479064
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
    Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
    Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Onset of effect of an i.v. ranitidine bolus].
    Dammann HG; Müller P; Simon B
    Anaesthesist; 1982; 31(9):456-7. PubMed ID: 6293334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic].
    Bretagne JF; Reymann JM; Tassou JJ; Allain H; Gosselin A; Gastard J
    Gastroenterol Clin Biol; 1983 Apr; 7(4):355-61. PubMed ID: 6135641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers.
    Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A
    Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidine.
    Koch KM; O'Connor-Semmes RL; Davis IM; Yin Y
    J Pharm Sci; 1998 Sep; 87(9):1097-100. PubMed ID: 9724561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.